Abstract: Ethylidene hydrazine (4a,b) and thiazolidin-4-one (5) derivatives were synthesized by the reaction of ethylidenethiosemicarbazide derivative (3a) with a-haloketone/ethyl bromoacetate, respectively. Hetrocyclization of ethylideneacetohydrazide derivative (7) with o-phenolic aldehydes gave the corresponding coumarin derivatives (8,9). The interaction of 7 with acetylacetone afforded the corresponding pyridine derivative (10). Treatment of the arylidene derivative 11b with malononitrile afforded the corresponding pyran derivative (12). The new products 3-12 were subjected to IR, 1 H NMR and mass spectra studies.
INTRODUCTION
Naphthofuran derivatives exhibit very potent antibacterial [1] [2] [3] [4] [5] and antiparasitic properties 2, 3, 6, 7 but some were shown to be mutagenic in bacteria [8] [9] [10] and in mammalian cell systems in vivo and in vitro. [11] [12] [13] [14] Encouraged by these observations, some new naphtho [2,1-b] furan derivatives, which might exhibit enhanced antimicrobial activities owing to the incorporation of different pharecophores into their structures, were synthesized. hydrazide (3b), respectively. The thiosemicarbazone 3a was used as the key intermediate in the synthesis of the desired thiazoles via their interaction with different a-halocarbonyl derivatives. Thus, the reaction of 3a with phenacyl bromide and/or chloroacetone in refluxing ethanol in the presence of sodium acetate afforded the thiazole derivatives 4a,b, respectively, while with ethyl bromoacetate the thiazolidin-4-one 5 was afforded (Scheme 1). Condensation of thiazolidin-4-one 5 with p-methoxybenzaldehyde and/or p-chlorobenzaldehyde in ethanol containing piperidine as a base gave the arylidene derivatives 6a,b, respectively (Scheme 1).
Structures of 3, 4, 5 and 6 were established from their microanalysis and spectral data (Tables I-III Interaction of 7 with salicylaldehyde or 2-hydroxy-1-naphthaldehyde afforded the chromene derivatives 8 and 9, respectively, while with acetylacetone the pyridine derivative 10 was obtained (Scheme 2). Condensation of 7 with p-tolua-ldehyde or p-anisaldehyde afforded the arylidene derivatives 11a,b. Reaction of the arylidene derivative 11b with malononitrile afforded the pyranone derivative 12. The structure of 12 was further confirmed by independent synthesis via direct condensation of 7 with p-methoxy-a-cyanocinnamonitrile in refluxing ethanol / piperidine (Scheme 2).
The structrures of 7, 8, 9, 10, 11 and 6 were established from their microanalysis and spectral data (Tables I-III The most important peaks observed in the mass spectra of naphtho [2,1-b] furan derivatives 3a-12 are listed in Table I and are arranged in columns according to the presumed composition.
The mass spectra of compounds 5, 6b and 7 are characterized by intense molecular ion peaks as the base peak and the other molecular ions were detected in high abundance, except for compounds 9 and 12 which contain chromene and a-pyran-2-one moieties, respectively, when they were detected in low abundance.
Their high stability is due to the extension of the conjugation of the furan ring to the naphthofuran system. The main fragments were formed by elimination of the side groups attached to the ethylidenamino function to give fragments at m/z: 209 and 208, followed by successive elimination of CH 3 , H, CN and CO to give fragments at m/z: 194, 193, 167, 165 and 139 (Scheme 3).
BIOLOGICAL ACTIVITIES
The antimicrobial investigations revealed that compound 4a possesses moderate activity (zone inhibition between 8-12 mm whereas for the standard drug, zone inhibition 12-15 mm) against all the tested microorganisms (Table IV) except fungi (Candida albicans, Aspergillus niger). On the other hand the remaining compounds exhibited weak or no activity against all the tested organisms. EXPERIMENTAL Melting points were measured using a melting point apparatus (Stuart Scientific Co., UK) and remained uncorrected. The IR spectra were recorded on a Shimadzu IR 440 spectrophotometer (Shimadzu, Japan) in KBr. The 1 H NMR spectra were measured on a Varian Mercury (300 MHz) spectrometer (Varian, UK), using TMS as the internal standard and DMSO-d 6 as the solvent. Mass spectra were run on a Shimadzu GC-MS QP 1000 EX mass spectrometer. Microanalytical data were obtained from the Microanalytical Unit at Center, Faculty of Science, Cairo Univerisity (Egypt). Spectral and microanalytical data are given in Tables I-III. The paper discs were manufactured by Bristol-Myers Squibb, Giza, Egypt.
Synthesis of 1-[1-(naphtho[2,1-b]furan-2-yl)ethylidene]thiosemicarbazide (3a) and 1-[1-(naphtho[2,1-b]furan-2-yl)ethylidene]thiocarbonohydrazide (3b)
A mixture of 2-acetylnaphtho[2,1-b]furan (1) (0.01 mol) and thiosemicarbazide or thiocarbonohydrazide (2) (0.01 mol) in ethanol (30 mL) was refluxed for 3 h. The solid which separated on heating was filtered off and recrystallized from the appropriate solvent to give 3a,b.
Synthesis of 2-(4-phenyl/or methyl thiazol-2(3H)-ylidene)-1-[1-(naphtho[2,1-b]furan-2-yl)ethylidene]hydrazine (4a,b)
A mixture of 3a (0.01 mol) and phenacyl bromide or chloroacetone (0.01 mol) and fused sodium acetate (0.02 mol) in ethanol (40 mL) was refluxed for 2 h. The obtained product was collected by filtration, washed with water and recrystallized from the appropriate solvent to give 4a,b.
Synthesis of 2-[1-(naphtho[2,1-b]furan-2-yl-ethylidene)hydrazono]thiazolidin-4-one (5)
A mixture of 3a (0.01 mol), ethyl bromoacetate (0.01 mol) and fused sodium acetate (0.02 mol) in ethanol (40 mL) was refluxed for 2h. The obtained product was collected by filtration, washed with water and recrystallized from acetic acid to give 5.
Synhtesis of 5-(4-methyl/or chloro benzylidene)-2-[(1-(naphtho[2,1-b]furan-2-yl)ethylidene)hydrazono]thiazolidin-4-one (6a,b)
A mixture of 5 (0.01 mol), the appropriate aromatic aldehyde (0.01 mol) in ethanol (30 ml) and a few drops of piperidine was refluxed for 3 h. The solid product was collected by filtration and recrystallized from the appropriate solvent to give 6a,b.
Synthesis of 2-cyano-N'-[1-(naphtho[2,1-b]furan-2-yl)ethylidene]acetohydrazide (7)
A mixture of 1 (0.01 mol) and cyanoacetohydrazide (0.01 mol) in ethanol (30 mL) was refluxed for 3 h. The solid which separated on heating was filtered off and recrystallized from dioxane to give 7. (8) 208 (11) 194 (35) 193 (26) 165 (49) 139 (68) 384 (100), 281 (95), 266 (26), 36
Synthesis of 2-imino-N'-[1-(naphtho[2,1-b]furan-2-yl)ethylidene]-2H-chromene-3-carbohydrazide (8)
To a mixture of 7 (0.01 mol) and salicylaldehyde (0.01 mol) in ethanol (50 mL), a few drops of piperidine was added as catalyst. The reaction mixture was refluxed for 3 h. The solid product was collected by filtration and recrystallized from DMF to give 8.
Synthesis of 3-imino-
To a mixture of 7 (0.01 mol) and 2-hydroxy-1-naphthaldehyde (0.01 mol) in ethanol (50 mL), a few drops of piperidine was added as catalyst. The reaction mixture was refluxed for 3 h. The isolated product was collected and recrystallized from DMF to give 9.
Synthesis of 1-[1-(naphtho[2,1-b]furan-2-yl)ethylideneamino]-1,2-dihydro-4,6-dimethyl-2-oxopyridine-3-carbonitrile (10)
To a mixture of 7 (0.01 mol) and acetylacetone (0.01 mol), a few drops of piperidine was added as catalyst. The reaction was fused in oil bath at 150°C for 1 h. The isolated product was collected and recrystallized from dioxane to give 10.
Synthesis of 2-cyano-3-(4-substituted phenyl)-N'-[1-(naphtho[2,1-b]furan-2-yl)ethylidene]acrylohydrazide (11a,b)
A mixture of 3 (0.01 mol), the appropriate aromatic aldehydes (0.01 mol) in ethanol (30 mL) and a few drops of piperidine was refluxed for 3 h. The solid product was collected by filtration and recrystallized from the proper solvent to give 11a,b.
Synthesis of 6-[2-(1-(naphtho[2,1-b]furan-2-yl)ethylidene)hydrazino]-4-(4-methoxyphenyl)-2-oxo-2H-pyran-3,5-dicarbonitrile (12).
Method A. To a mixture of 11b (0.01 mol) and malononitrile (0.01 mol) in ethanol (50 mL), a few drops of piperidine was added as catalyst. The reaction mixture was refluxed for 3 h. The isolated product was collected and recrystallized from DMF to give 12.
Method B. To a solution of 7 (0.01 mol) and p-methoxy-a-cyanocinnamonitrile (0.01 mol) in ethanol (50 mL), a few drops of piperidine was added as catalyst. The reaction mixture was refluxed for 3 h. The isolated product was collected and recrystallized from DMF to give 12; m.p. and mixed m.p determined with an authentic sample gave no depression.
Antibacterial activity
The newly synthesized compounds were screened for their antimicrobial activities in vitro against two species of Gram-positive bacteria Bacillus subtilis (ATCC 7972) (BS), Staphylococcus aureus (NCTC 7447) (SA), two Gram-negative bacteria, Escherichia coli (NCTC 10416) (EC), Pseudomonas aeruginosa (ATCC 10415) (PA) and two fungi, Candida albicans (IMRU 3669) (CA), and Aspergillus niger (ATCC 6275) (AN) microorganisms. The activities of these compounds were tested using disc diffusion method. 16, 17 The area of zone of inhibition was measured using neomycin (30 mg) as standard antibiotic.
The tested compounds were dissolved in N,N-dimethylformamide ( DMF) to get a solution of 1 mg mL -1 . The inhibition zones were measured in millimeters at the end of an incubation period of 48 h at 28°C
. N,N-Dimethylformamide ( DMF) showed no inhibition zones. Standard antibiotic neomycin was used as a reference (Table IV) . Derivati etilidenhidrazina (4a,b) i tiazolidin-4-ona (5) sintetizovani su u reakciji derivata etilidentiosemikarbazida (3a) sa a-haloketonom odnosno etilbromoacetatom. Hetrociklizacija derivata etilidenacetohidrazida (7) sa o-fenolnim aldehidima daje odgovaraju}e kumarinske derivate (8, 9) . Interakcija 7 sa acetilacetonima dala je odgovaraju}i derivat piridina (10) . Tretirawe ariliden-derivata 11b sa malononitrilom dala je odgovaraju}i derivat pirana (12) . Struktura novih produkata 3-12 prou~avana je preko IR, 1 H NMR i masenih spektara. 
